Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Protara Therapeutics, Inc. (PRTO) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/18/2023 4 Fry Hannah (VP, Controller) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 10,075 shares @ $2.56, valued at $25.8k
07/05/2023 4 Bandari Jathin (Chief Medical Officer) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 682 shares @ $2.46, valued at $1.7k
06/08/2023 4 Smith Cynthia (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
06/08/2023 4 BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
06/08/2023 4 GARCEAU ROGER (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
06/08/2023 4 SARGEN GREGORY (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
06/08/2023 4 Levy Richard S (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
06/08/2023 4 Solomon Michael Edward (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
06/08/2023 4 Huang Jane (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
06/08/2023 4 Flannelly Barry P (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
01/30/2023 4 Fabbio Patrick (CFO) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 300,000 options to buy @ $3.14, valued at $942k
01/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2023 4 Fry Hannah (VP, Controller) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 5,900 shares @ $0
Granted 35,400 options to buy @ $3.02, valued at $106.9k
01/20/2023 4 Zummo Jacqueline (Chf Scientific Operations Off) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 19,900 shares @ $0
Granted 119,300 options to buy @ $3.02, valued at $360.3k
01/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2023 4 Zummo Jacqueline (Chf Scientific Operations Off) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 5,225 shares @ $3, valued at $15.7k
01/11/2023 4 Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 5,855 shares @ $3, valued at $17.6k
01/11/2023 4 Bandari Jathin (Chief Medical Officer) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,876 shares @ $3, valued at $5.6k
01/04/2023 4 Zummo Jacqueline (Chf Scientific Operations Off) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 2,159 shares @ $2.8, valued at $6k
01/04/2023 4 Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 6,604 shares @ $2.8, valued at $18.5k
01/04/2023 4 Fry Hannah (VP, Controller) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 361 shares @ $2.8, valued at $1k
12/30/2022 4 Opaleye Management Inc. (10% Owner) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Sold 13,173 shares @ $2.7111, valued at $35.7k
Sold 2,300 shares @ $2.7111, valued at $6.2k
09/15/2022 4 Opaleye Management Inc. (10% Owner) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Bought 14,100 shares @ $3.98, valued at $56.1k
Bought 2,500 shares @ $3.98, valued at $10k
Bought 5,000 shares @ $3.8, valued at $19k
Bought 2,300 shares @ $3.8, valued at $8.7k
08/15/2022 4 Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Bought 9,065 shares @ $3.84, valued at $34.8k
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Bandari Jathin (Chief Medical Officer) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 682 shares @ $3.22, valued at $2.2k
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Smith Cynthia (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.5, valued at $35k
06/09/2022 4 SARGEN GREGORY (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.5, valued at $35k
06/09/2022 4 Huang Jane (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.5, valued at $35k
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Flannelly Barry P (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.5, valued at $35k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy